So, why are companies allowed to lie and mislead users trying to purchase CBD products? This a result of the industry lacking formal regulation. This is very controversial because it opens the doors for big pharmaceutical companies and lobbyists to get away with practices that may prevent CBD from becoming easily accessible to those who need it. Hopefully, legislation like the 2018 Farm Bill will help establish competitive practices in the industry that will benefit the consumer in the long run.
Most human studies of CBD have been done on people who have seizures, and the FDA recently approved the first CBD-based drug, Epidiolex, for rare forms of epilepsy. Clinical trials for other conditions are promising, but tiny. In one Brazilian study published in 2011 of people with generalized social anxiety disorder, for example, taking a 600-mg dose of CBD (higher than a typical dose from a tincture) lessened discomfort more than a placebo, but only a dozen people were given the pill.
CBD is a compound found in the hemp plant, also known as Cannabis Sativa L. CBD products that are available on the market, such as Green Roads products, are made from industrial hemp. The main difference between hemp and industrial hemp is that the latter has Non-Detectable THC. THC, or tetrahydrocannabinol, is a psychotropic chemical found in cannabis. The CBD products available to all customers in the U.S. contain very small amounts of THC.